Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 261
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots Phase 3
Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA Funds Psychedelic Therapy for Veterans; AbbVie Paid $900M Upfront for Psychedelic Candidate
Review: Colorado Psychedelic Cup 2025
Dr Ros Watts – Building Communities and Connection
The Psychedelic News Feed: October 27 – November 02, 2025
MindMed Becomes Second Psychedelic Drug Development Company to List on the...
PsyBio and Miami University Broaden Partnership Agreement for the Continued Advancement...
Cybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003
Mydecine to Report Full Year 2020 Financial Results on May 3,...
Numinus Announces Phase 1 Clinical Trial of Natural Psilocybin Mushroom Extraction...
Red Light Holland and Headland West Indies Lead #SVGStrong, a Relief...
Psychedelic Bulletin: MindMed to List on Nasdaq; Atai IPO Unveiled; Champignon...
PTSF56 – Data vs. Spin, with Tim Cools of Psychedelic Experience
MindMed To Commence Trading on Nasdaq
Champignon Brands Announces Revocation of Cease Trade Orders
1
...
260
261
262
...
301
Page 261 of 301